These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37870552)

  • 1. Use of second-generation antidiabetic medication among a nationally representative sample.
    Truong B; Li Y; Zheng J; Qian J
    Am J Manag Care; 2023 Oct; 29(10):e307-e316. PubMed ID: 37870552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization and impact of SLGT2 inhibitors among diabetes patients in a nationally representative survey: Findings from NHANES 2013-2020.
    Shen TH; Farley JF
    J Diabetes Complications; 2023 Nov; 37(11):108625. PubMed ID: 37804691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic drug therapy of African-American and white community-dwelling elderly over a 10-year period.
    Lindblad CI; Hanlon JT; Artz MB; Fillenbaum GG; McCarthy TC
    J Am Geriatr Soc; 2003 Dec; 51(12):1748-53. PubMed ID: 14687353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization.
    Sun P; Lian J
    Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic drug use trends in patients with type 2 diabetes mellitus and chronic kidney disease: A cross-sectional analysis of the National Health and Nutrition Examination Survey.
    Gor D; Gerber BS; Walton SM; Lee TA; Nutescu EA; Touchette DR
    J Diabetes; 2020 May; 12(5):385-395. PubMed ID: 31652390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States.
    Koro CE; Lee BH; Bowlin SJ
    Clin Ther; 2009 Nov; 31(11):2608-17. PubMed ID: 20110005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction.
    Kogut SJ; Johnson S; Higgins T; Quilliam B
    J Manag Care Pharm; 2012 May; 18(4):297-310. PubMed ID: 22548690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.
    Rwegerera GM
    Pan Afr Med J; 2014; 17():252. PubMed ID: 25309652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study.
    Liu CH; Chen ST; Chang CH; Chuang LM; Lai MS
    Public Health; 2017 Nov; 152():20-27. PubMed ID: 28719837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA-DM cohort study.
    Sakai R; Hashimoto Y; Ushigome E; Okamura T; Hamaguchi M; Yamazaki M; Oda Y; Fukui M
    J Diabetes Investig; 2019 Mar; 10(2):458-465. PubMed ID: 30136448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes.
    Lavikainen P; Aarnio E; Jalkanen K; Tirkkonen H; Rautiainen P; Laatikainen T; Martikainen J
    BMC Health Serv Res; 2020 Nov; 20(1):1095. PubMed ID: 33246453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional and longitudinal evaluations in the CORDIALLY
    Prázný M; Suplotova L; Gumprecht J; Kamenov Z; Fülöp T; Medvedchikov A; Rosenzweig D; Aleksandric M
    Cardiovasc Diabetol; 2022 Oct; 21(1):203. PubMed ID: 36209118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
    McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
    J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
    [No Abstract]   [Full Text] [Related]  

  • 17. Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
    Hong YR; Hincapie-Castillo JM; Xie Z; Segal R; Mainous AG
    JAMA Netw Open; 2020 Jun; 3(6):e208968. PubMed ID: 32579194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States.
    Tan X; Yang L; Khunti K; Zhang R; Zhang Y; Rajpathak S; Yu M
    Diabetes Obes Metab; 2021 Oct; 23(10):2251-2260. PubMed ID: 34132017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and socioeconomic determinants of access to care: A subgroup disparity analysis using new equity-focused measurements.
    Qi M; Santos H; Pinheiro P; McGuinness DL; Bennett KP
    PLoS One; 2023; 18(11):e0290692. PubMed ID: 37972008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.